Osaic Holdings
INMB icon

Osaic Holdings’s INmune Bio INMB Stock Holding History

Osaic Holdings’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.03K Sell
3,565
-600
-14% -$855 ﹤0.01% 6785
2025
Q4 		$6.5K Sell
4,165
-950
-19% -$1.7K ﹤0.01% 6558
2025
Q3 		$10.5K Sell
5,115
-7,395
-59% -$16.9K ﹤0.01% 6326
2025
Q2 		$28.9K Sell
12,510
-1,415
-10% -$10.4K ﹤0.01% 5432
2025
Q1 		$109K Buy
13,925
+11,625
+505% +$92.3K ﹤0.01% 4107
2024
Q4 		$10.7K Sell
2,300
-4,400
-66% -$22.9K ﹤0.01% 5759
2024
Q3 		$36.1K Sell
6,700
-1,463
-18% -$10.4K ﹤0.01% 4970
2024
Q2 		$72K Sell
8,163
-4,107
-33% -$40.5K ﹤0.01% 4387
2024
Q1 		$144K Buy
12,270
+1,570
+15% +$19K ﹤0.01% 3955
2023
Q4 		$120K Buy
10,700
+2,200
+26% +$18.4K ﹤0.01% 4298
2023
Q3 		$57.5K Sell
8,500
-2,700
-24% -$22.4K ﹤0.01% 4898
2023
Q2 		$102K Buy
11,200
+3,265
+41% +$26.2K ﹤0.01% 4419
2023
Q1 		$51.3K Sell
7,935
-1,315
-14% -$10.6K ﹤0.01% 4935
2022
Q4 		$59K Buy
9,250
+3,200
+53% +$22.7K ﹤0.01% 4809
2022
Q3 		$38K Buy
6,050
+493
+9% +$4.33K ﹤0.01% 5096
2022
Q2 		$49K Sell
5,557
-27,543
-83% -$205K ﹤0.01% 4978
2022
Q1 		$279K Sell
33,100
-2,638
-7% -$23.7K ﹤0.01% 3742
2021
Q4 		$364K Buy
35,738
+23,568
+194% +$349K ﹤0.01% 3378
2021
Q3 		$237K Sell
12,170
-15,092
-55% -$291K ﹤0.01% 3747
2021
Q2 		$479K Buy
27,262
+19,280
+242% +$260K ﹤0.01% 3075
2021
Q1 		$94K Buy
7,982
+1,982
+33% +$35.7K ﹤0.01% 4397
2020
Q4 		$103K Hold
6,000
– – ﹤0.01% 4013
2020
Q3 		$62K Buy
6,000
+5,800
+2,900% +$59K ﹤0.01% 4149
2020
Q2 		$1K Sell
200
-100
-33% -$504 ﹤0.01% 5947
2020
Q1 		$1K Buy
+300
New +$1.35K ﹤0.01% 5863

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings's INMB Position: Q1 2026 in Review

Osaic Holdings reduced its INmune Bio (INMB) stake by 14% in Q1 2026, selling an estimated $855 and leaving 3,565 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #6785.

Osaic Holdings first reported a position in INMB in Q1 2020 and has held it in 25 quarters since. The position peaked at $479K in Q2 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Osaic Holdings held 3,565 shares of INmune Bio worth $4.03K as of Q1 2026.
  • Osaic Holdings sold 600 INmune Bio shares in Q1 2026, an estimated $855.
  • INmune Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6785 holding.
  • Osaic Holdings first reported a position in INmune Bio in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's INmune Bio position peaked at $479K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.